logo
Sign in

TRX Stock Price, Chart, Stats & News

Tissue Regenix Group plc
Save

Tissue Regenix Group plc (TRX) does not currently pay a dividend.

5.16M
Market cap
Current P/E
112.36x
Forward P/E

TRX chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Tissue Regenix Group plc, established in 2006 and headquartered in Garforth, United Kingdom, is a medical technology enterprise dedicated to advancing the fields of tissue engineering and regenerative medicine. Operating across the United States and international markets, the company develops and commercializes sophisticated platform technologies. Its operations are organized into BioSurgery, Orthopaedics & Dental, and GBM-V & Cardiac divisions.

Similar securities

Based on sector and market capitalization

Report issue